Dysbiotic infection in the stomach

World Journal of Gastroenterology

Volumn 21, Issue 40, 2015, Pages 11450-11457

  Iizasa, Hisashi ^a   Ishihara, Shyunji ^a   Richardo, Timmy ^a   Kanehiro, Yuichi ^a   Yoshiyama, Hironori ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Dysbiosis; Epstein Barr virus; Helicobacter pylori; Microbiota; Stomach

Indexed keywords

CARCINOGENICITY; CELL POPULATION; DIETARY INTAKE; DYSBIOSIS; DYSBIOTIC INFECTION; DYSPEPSIA; EPITHELIUM CELL; EPSTEIN BARR VIRUS INFECTION; GASTRIC MUCOSA; GASTROINTESTINAL INFECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE DYSREGULATION; IMMUNOCOMPETENT CELL; INTESTINE FLORA; IRRITABLE COLON; KINGELLA; KINGELLA DENITRIFICANS; META ANALYSIS (TOPIC); NONHUMAN; REVIEW; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH DISEASE; STOMACH EPITHELIUM; STOMACH PH; SYSTEMATIC REVIEW (TOPIC); UPPER GASTROINTESTINAL TRACT; HELICOBACTER INFECTIONS; HOMEOSTASIS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; RISK FACTOR; STOMACH; STOMACH ACID; STOMACH TUMOR;

DYSBIOSIS; GASTRIC ACID; GASTROINTESTINAL MICROBIOME; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; RISK FACTORS; STOMACH; STOMACH NEOPLASMS;

EID: 84944916553     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i40.11450     Document Type: Review

References (77)

1. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489: 220-230 [PMID: 22972295 DOI: 10.1038/NATURE11550].
2. Doolittle JM, Webster-Cyriaque J. Polymicrobial infection and bacterium-mediated epigenetic modification of DNA tumor viruses contribute to pathogenesis. MBio 2014; 5: E01015-e01014 [PMID: 24781742 DOI: 10.1128/MBIO.01015-14].
3. Pagano JS, Blaser M, Buendia MA, Damania B, Khalili K, Raab- Traub N, Roizman B. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 2004; 14: 453-471 [PMID: 15489139 DOI: 10.1016/J.SEMCANCER.2014.04.004].
4. Rickinson AB. Co-infections, inflammation and oncogenesis: future directions for EBV research. Semin Cancer Biol 2014; 26: 99-115 [PMID: 24751797 DOI: 10.1016/J.SEMCANCER.2014.04.004].
5. Yoshiyama H, Nakazawa T. Unique mechanism of Helicobacter pylori for colonizing the gastric mucus. Microbes Infect 2000; 2: 55-60 [PMID: 10717541].
6. Husebye E, Skar V, Høverstad T, Melby K. Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people. Gut 1992; 33: 1331-1337 [PMID: 1446855].
7. Belitsos PC, Greenson JK, Yardley JH, Sisler JR, Bartlett JG. Association of gastric hypoacidity with opportunistic enteric infections in patients with AIDS. J Infect Dis 1992; 166: 277-284 [PMID: 1634799].
8. Okamoto T, Hayashi Y, Mizuno H, Yanai H, Nishikawa J, Nakazawa T, Iizasa H, Jinushi M, Sakaida I, Yoshiyama H. Colonization of an acid resistant Kingella denitrificans in the stomach may contribute to gastric dysbiosis by Helicobacter pylori. J Infect Chemother 2014; 20: 169-174 [PMID: 24462438 DOI: 10.1016/J.JIAC.2013.09.007].
9. Shin SC, Kim SH, You H, Kim B, Kim AC, Lee KA, Yoon JH, Ryu JH, Lee WJ. Drosophila microbiome modulates host developmental and metabolic homeostasis via insulin signaling. Science 2011; 334: 670-674 [PMID: 22053049 DOI: 10.1126/SCIENCE.1212782].
10. Patwa LG, Fan TJ, Tchaptchet S, Liu Y, Lussier YA, Sartor RB, Hansen JJ. Chronic intestinal inflammation induces stress-response genes in commensal Escherichia coli. Gastroenterology 2011; 141: 1842-51. e1-10 [PMID: 21726510 DOI: 10.1053/J.GASTRO.2011.06.064].
11. Nardone G, Compare D. The human gastric microbiota: Is it time to rethink the pathogenesis of stomach diseases? United European Gastroenterol J 2015; 3: 255-260 [PMID: 26137299 DOI: 10.1177/2050640614566846].
12. Zilberstein B, Quintanilha AG, Santos MA, Pajecki D, Moura EG, Alves PR, Maluf Filho F, de Souza JA, Gama-Rodrigues J. Digestive tract microbiota in healthy volunteers. Clinics (Sao Paulo) 2007; 62: 47-54 [PMID: 17334549].
13. Fraher MH, O'Toole PW, Quigley EM. Techniques used to characterize the gut microbiota: A guide for the clinician. Nat Rev Gastroenterol Hepatol 2012; 9: 312-322 [PMID: 22450307 DOI: 10.1038/NRGASTRO.2012.44].
14. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA 2006; 103: 732-737 [PMID: 16407106].
15. Li XX, Wong GL, To KF, Wong VW, Lai LH, Chow DK, Lau JY, Sung JJ, Ding C. Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PLoS One 2009; 4: E7985 [PMID: 19956741 DOI: 10.1371/JOURNAL.PONE.0007985].
16. Delgado S, Cabrera-Rubio R, Mira A, Suárez A, Mayo B. Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods. Microb Ecol 2013; 65: 763-772 [PMID: 23397369 DOI: 10.1007/S00248-013-0192-5].
17. Andersson AF, Lindberg M, Jakobsson H, Bäckhed F, Nyrén P, Engstrand L. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 2008; 3: E2836 [PMID: 18665274 DOI: 10.1371/JOURNAL.PONE.0002836].
18. Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F, Karaoz U, Contreras M, Blaser MJ, Brodie EL, Dominguez-Bello MG. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J 2011; 5: 574-579 [PMID: 20927139 DOI: 10.1038/ISMEJ.2010.149].
19. Osaki T, Matsuki T, Asahara T, Zaman C, Hanawa T, Yonezawa H, Kurata S, Woo TD, Nomoto K, Kamiya S. Comparative analysis of gastric bacterial microbiota in Mongolian gerbils after long-term infection with Helicobacter pylori. Microb Pathog 2012; 53: 12-18 [PMID: 22783557].
20. Hornsby MJ, Huff JL, Kays RJ, Canfield DR, Bevins CL, Solnick JV. Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity island-dependent manner. Gastroenterology 2008; 134: 1049-1057 [PMID: 18395086 DOI: 10.1053/J.GASTRO.2008.01.018].
21. Pütsep K, Normark S, Boman HG. The origin of cecropins; implications from synthetic peptides derived from ribosomal protein L1. FEBS Lett 1999; 451: 249-252 [PMID: 10371199].
22. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest 2004; 113: 321-333 [PMID: 14755326].
23. Müller A, Solnick JV. Inflammation, immunity, and vaccine development for Helicobacter pylori. Helicobacter 2011; 16 Suppl 1: 26-32 [PMID: 21896082 DOI: 10.1111/J.1523-5378.2011.00877. X].
24. Oh JD, Kling-Bäckhed H, Giannakis M, Engstrand LG, Gordon JI. Interactions between gastric epithelial stem cells and Helicobacter pylori in the setting of chronic atrophic gastritis. Curr Opin Microbiol 2006; 9: 21-27 [PMID: 16406776].
25. Wroblewski LE, Peek RM. Targeted disruption of the epithelialbarrier by Helicobacter pylori. Cell Commun Signal 2011; 9: 29 [PMID: 22044698 DOI: 10.1186/1478-811X-9-29].
26. Engstrand L, Lindberg M. Helicobacter pylori and the gastric microbiota. Best Pract Res Clin Gastroenterol 2013; 27: 39-45 [PMID: 23768551 DOI: 10.1016/J.BPG.2013.03.016].
27. Takada K. Epstein-Barr virus and gastric carcinoma. Mol Pathol 2000; 53: 255-261 [PMID: 11091849].
28. Iizasa H, Nanbo A, Nishikawa J, Jinushi M, Yoshiyama H. Epstein-Barr Virus (EBV)-associated gastric carcinoma. Viruses 2012; 4: 3420-3439 [PMID: 23342366 DOI: 10.3390/V4123420].
29. Kitajima Y, Ohtaka K, Mitsuno M, Tanaka M, Sato S, Nakafusa Y, Miyazaki K. Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer. Oncol Rep 2008; 19: 197-202 [PMID: 18097595].
30. Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 2000; 26: 16-17 [PMID: 10973239].
31. Ferrasi AC, Pinheiro NA, Rabenhorst SH, Caballero OL, Rodrigues MA, de Carvalho F, Leite CV, Ferreira MV, Barros MA, Pardini MI. Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability. World J Gastroenterol 2010; 16: 312-319 [PMID: 20082476].
32. Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, Hui WM, Rashid A, Kwong YL. romoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003; 52: 502-506 [PMID: 12631658].
33. Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M, Kitano S, Hirohashi S. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol 2004; 164: 689-699 [PMID: 14742272].
34. Kaneda A, Matsusaka K, Aburatani H, Fukayama M. Epstein-Barr virus infection as an epigenetic driver of tumorigenesis. Cancer Res 2012; 72: 3445-3450 [PMID: 22761333 DOI: 10.1158/0008-5472].
35. Nishikawa J, Yoshiyama H, Iizasa H, Kanehiro Y, Nakamura M, Nishimura J, Saito M, Okamoto T, Sakai K, Suehiro Y, Yamasaki T, Oga A, Yanai H, Sakaida I. Epstein-barr virus in gastric carcinoma. Cancers (Basel) 2014; 6: 2259-2274 [PMID: 25386788 DOI: 10.3390/CANCERS6042259].
36. Cárdenas-Mondragón MG, Carreón-Talavera R, Camorlinga- Ponce M, Gomez-Delgado A, Torres J, Fuentes-Pananá EM. Epstein Barr virus and Helicobacter pylori co-infection are positively associated with severe gastritis in pediatric patients. PLoS One 2013; 8: E62850 [PMID: 23638154 DOI: 10.1371/journal.pone.0062850].
37. Shukla SK, Prasad KN, Tripathi A, Ghoshal UC, Krishnani N, Husain N. Expression profile of latent and lytic transcripts of epstein-barr virus in patients with gastroduodenal diseases: A study from northern India. J Med Virol 2012; 84: 1289-1297 [PMID: 22711358 DOI: 10.1002/jmv.23322].
38. Minoura-Etoh J, Gotoh K, Sato R, Ogata M, Kaku N, Fujioka T, Nishizono A. Helicobacter pylori-associated oxidant monochloramine induces reactivation of Epstein-Barr virus (EBV) in gastric epithelial cells latently infected with EBV. J Med Microbiol 2006; 55: 905-911 [PMID: 16772418].
39. Hirano A, Yanai H, Shimizu N, Okamoto T, Matsubara Y, Yamamoto K, Okita K. Evaluation of epstein-barr virus DNA load in gastric mucosa with chronic atrophic gastritis using a real-time quantitative PCR assay. Int J Gastrointest Cancer 2003; 34: 87-94 [PMID: 15361640].
40. Matsusaka K, Funata S, Fukayama M, Kaneda A. DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus. World J Gastroenterol 2014; 20: 3916-3926 [PMID: 24744581 DOI: 10.3748/WJG.V20.I14.3916].
41. Yanai H, Murakami T, Yoshiyama H, Takeuchi H, Nishikawa J, Nakamura H, Okita K, Miura O, Shimizu N, Takada K. Epstein- Barr virus-associated gastric carcinoma and atrophic gastritis. J Clin Gastroenterol 1999; 29: 39-43 [PMID: 10405229].
42. Lagergren J, Lindam A, Mason RM. Gastric stump cancer after distal gastrectomy for benign gastric ulcer in a population-based study. Int J Cancer 2012; 131: E1048-E1052 [PMID: 22532306 DOI: 10.1002/IJC.27614].
43. Yamamoto N, Tokunaga M, Uemura Y, Tanaka S, Shirahama H, Nakamura T, Land CE, Sato E. Epstein-Barr virus and gastric remnant cancer. Cancer 1994; 74: 805-809 [PMID: 8039108].
44. Nishikawa J, Yanai H, Hirano A, Okamoto T, Nakamura H, Matsusaki K, Kawano T, Miura O, Okita K. High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction. Scand J Gastroenterol 2002; 37: 825-829 [PMID: 12190097].
45. Iskra S, Kalla M, Delecluse HJ, Hammerschmidt W, Moosmann A. Toll-like receptor agonists synergistically increase proliferation and activation of B cells by Epstein-Barr virus. J Virol 2010; 84: 3612-3623 [PMID: 20089650 DOI: 10.1128/JVI.01400-09].
46. Ueda S, Uchiyama S, Azzi T, Gysin C, Berger C, Bernasconi M, Harabuchi Y, Zinkernagel AS, Nadal D. Oropharyngeal group A streptococcal colonization disrupts latent Epstein-Barr virus infection. J Infect Dis 2014; 209: 255-264 [PMID: 23935199 DOI: 10.1093/INFDIS/JIT428].
47. Imai K, Inoue H, Tamura M, Cueno ME, Inoue H, Takeichi O, Kusama K, Saito I, Ochiai K. The periodontal pathogen Porphyromonas gingivalis induces the Epstein-Barr virus lytic switch transactivator ZEBRA by histone modification. Biochimie 2012; 94: 839-846 [PMID: 22178321 DOI: 10.1016/J.BIOCHI.2011.12.001].
48. Takada K, Shimizu N, Sakuma S, Ono Y. trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol 1986; 57: 1016-1022 [PMID: 3005608].
49. Ishihara S, Tada Y, Fukuba N, Oka A, Kusunoki R, Mishima Y, Oshima N, Moriyama I, Yuki T, Kawashima K, Kinoshita Y. Pathogenesis of irritable bowel syndRome-review regarding associated infection and immune activation. Digestion 2013; 87: 204-211 [PMID: 23712295 DOI: 10.1159/000350054].
50. Ishihara S, Aziz M, Oshima N, Mishima Y, Imaoka H, Moriyama I, Kinoshita Y. Irritable bowel syndRome and inflammatory bowel disease: infectious gastroenteritis-related disorders? Clin J Gastroenterol 2009; 2: 9-16 [PMID: 26191801 DOI: 10.1007/s12328-008-0051-y].
51. Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N, Whorwell P. Guidelines on the irritable bowel syndRome: mechanisms and practical management. Gut 2007; 56: 1770-1798 [PMID: 17488783].
52. Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010; 7: 163-173 [PMID: 20101257 DOI: 10.1038/NRGASTRO.2010.4].
53. El-Salhy M. Irritable bowel syndRome: diagnosis and pathogenesis. World J Gastroenterol 2012; 18: 5151-5163 [PMID: 23066308 DOI: 10.3748/WJG.V18.I37.5151].
54. Gwee KA, Collins SM, Read NW, Rajnakova A, Deng Y, Graham JC, McKendrick MW, Moochhala SM. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndRome. Gut 2003; 52: 523-526 [PMID: 12631663].
55. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW, Collins SM, Corinaldesi R. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndRome. Gastroenterology 2004; 126: 693-702 [PMID: 14988823].
56. Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndRome and its relationship with psychological factors. J Gastroenterol Hepatol 2008; 23: 1689-1694 [PMID: 19120860 DOI: 10.1111/J.1440-1746.2008.05574.X].
57. Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, Stanghellini V, Corinaldesi R, Barbara G. Mucosal immune activation in irritable bowel syndRome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 2009; 104: 392-400 [PMID: 19174797 DOI: 10.1038/AJG.2008.94].
58. Chen J, Zhang Y, Deng Z. Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndRome. BMC Gastroenterol 2012; 12: 91 [PMID: 22816602 DOI: 10.1186/1471-230X-12-91].
59. Brint EK, MacSharry J, Fanning A, Shanahan F, Quigley EM. Differential expression of toll-like receptors in patients with irritable bowel syndRome. Am J Gastroenterol 2011; 106: 329-336 [PMID: 21102570 DOI: 10.1038/AJG.2010.438].
60. Belmonte L, Beutheu Youmba S, Bertiaux-Vandaële N, Antonietti M, Lecleire S, Zalar A, Gourcerol G, Leroi AM, Déchelotte P, Coëffier M, Ducrotté P. Role of toll like receptors in irritable bowel syndRome: differential mucosal immune activation according to the disease subtype. PLoS One 2012; 7: E42777 [PMID: 23028414 DOI: 10.1371/JOURNAL.PONE.0042777].
61. Schoepfer AM, Schaffer T, Seibold-Schmid B, Müller S, Seibold F. Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol Motil 2008; 20: 1110-1118 [PMID: 18694443 DOI: 10.1111/J.1365-2982.2008.01166.X].
62. Alonso C, Guilarte M, Vicario M, Ramos L, Ramadan Z, Antolín M, Martínez C, Rezzi S, Saperas E, Kochhar S, Santos J, Malagelada JR. Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation. Gastroenterology 2008; 135: 163-172.e1 [PMID: 18455999 DOI: 10.1053/J.GASTRO.2008.03.036].
63. Miwa H, Watari J, Fukui H, Oshima T, Tomita T, Sakurai J, Kondo T, Matsumoto T. Current understanding of pathogenesis of functional dyspepsia. J Gastroenterol Hepatol 2011; 26 Suppl 3: 53-60 [PMID: 21443711 DOI: 10.1111/J.1440-1746.2011.06633.X].
64. Lee KJ, Tack J. Duodenal implications in the pathophysiology of functional dyspepsia. J Neurogastroenterol Motil 2010; 16: 251-257 [PMID: 20680163 DOI: 10.5056/JNM.2010.16.3.251].
65. Tack J, Demedts I, Dehondt G, Caenepeel P, Fischler B, Zandecki M, Janssens J. Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology 2002; 122: 1738-1747 [PMID: 12055579].
66. Mearin F, Pérez-Oliveras M, Perelló A, Vinyet J, Ibañez A, Coderch J, Perona M. Dyspepsia and irritable bowel syndRome after a Salmonella gastroenteritis outbreak: one-year followup cohort study. Gastroenterology 2005; 129: 98-104 [PMID: 16012939].
67. Futagami S, Itoh T, Sakamoto C. Systematic review with metaanalysis: post-infectious functional dyspepsia. Aliment Pharmacol Ther 2015; 41: 177-188 [PMID: 25348873 DOI: 10.1111/APT.13006].
68. Kindt S, Van Oudenhove L, Mispelon L, Caenepeel P, Arts J, Tack J. Longitudinal and cross-sectional factors associated with longterm clinical course in functional dyspepsia: A 5-year follow-up study. Am J Gastroenterol 2011; 106: 340-348 [PMID: 20978482 DOI: 10.1038/AJG.2010.406].
69. Futagami S, Shindo T, Kawagoe T, Horie A, Shimpuku M, Gudis K, Iwakiri K, Itoh T, Sakamoto C. Migration of eosinophils and CCR2-/CD68-double positive cells into the duodenal mucosa of patients with postinfectious functional dyspepsia. Am J Gastroenterol 2010; 105: 1835-1842 [PMID: 20461070 DOI: 10.1038/AJG.2010.151].
70. Li X, Chen H, Lu H, Li W, Chen X, Peng Y, Ge Z. The study on the role of inflammatory cells and mediators in post-infectious functional dyspepsia. Scand J Gastroenterol 2010; 45: 573-581 [PMID: 20163288 DOI: 10.3109/00365521003632576].
71. Dizdar V, Spiller R, Singh G, Hanevik K, Gilja OH, El-Salhy M, Hausken T. Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndRome and functional dyspepsia. Aliment Pharmacol Ther 2010; 31: 883-891 [PMID: 20132151 DOI: 10.1111/J.1365-2036.2010.04251.X].
72. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, Camporez JP, Shulman GI, Gordon JI, Hoffman HM, Flavell RA. Inflammasomemediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012; 482: 179-185 [PMID: 22297845 DOI: 10.1038/NATURE10809].
73. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505: 559-563 [PMID: 24336217 DOI: 10.1038/NATURE12820].
74. Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, Honda K, Ishikawa Y, Hara E, Ohtani N. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013; 499: 97-101 [PMID: 23803760 DOI: 10.1038/NATURE12347].
75. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. Dietary-fatinduced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 2012; 487: 104-108 [PMID: 22722865 DOI: 10.1038/NATURE11225].
76. Peleg AY, Hogan DA, Mylonakis E. Medically important bacterialfungal interactions. Nat Rev Microbiol 2010; 8: 340-349 [PMID: 20348933 DOI: 10.1038/NRMICRO2313].
77. Carlson E, Johnson G. Protection by Candida albicans of Staphylococcus aureus in the establishment of dual infection in mice. Infect Immun 1985; 50: 655-659 [PMID: 3905609].